Lista de obras - Salvatore Alfieri - Dominio Público Uruguay

A phase II study of sorafenib in recurrent and/or metastatic salivary gland carcinomas: Translational analyses and clinical impact.

artículo científico publicado en 2016

A randomized, double-blind, placebo controlled, phase II study to evaluate the efficacy of ginseng in reducing fatigue in patients treated for head and neck cancer

artículo científico publicado en 2020

A randomized, double-blind, placebo-controlled, multicenter study of a ginger extract in the management of chemotherapy-induced nausea and vomiting (CINV) in patients receiving high-dose cisplatin

artículo científico publicado en 2017

Activity of platinum and cetuximab in cutaneous squamous cell cancer not amenable to curative treatment

artículo científico publicado en 2019

Baseline MRI-Radiomics Can Predict Overall Survival in Non-Endemic EBV-Related Nasopharyngeal Carcinoma Patients

artículo científico publicado en 2020

Baseline neutrophil-to-lymphocyte ratio is associated with outcome of ipilimumab-treated metastatic melanoma patients

artículo científico publicado en 2015

Bone metastases from head and neck malignancies: Prognostic factors and skeletal-related events

scientific article published on 20 March 2019

Circulating pre-treatment Epstein-Barr virus DNA as prognostic factor in locally-advanced nasopharyngeal cancer in a non-endemic area.

artículo científico publicado en 2017

Dabrafenib in metastatic melanoma: a monocentric 'real life' experience

artículo científico publicado en 2016

Does a multidisciplinary team approach in a tertiary referral centre impact on the initial management of head and neck cancer?

artículo científico publicado en 2016

Efficacy and safety of single-agent pan-human epidermal growth factor receptor (HER) inhibitor dacomitinib in locally advanced unresectable or metastatic skin squamous cell cancer

scientific article published on 04 May 2018

Eliciting Preferences for Clinical Follow-Up in Patients with Head and Neck Cancer Using Best-Worst Scaling.

artículo científico publicado en 2017

Gene Expression Signatures for Head and Neck Cancer Patient Stratification: Are Results Ready for Clinical Application?

artículo científico publicado en 2017

Genomics in non-adenoid cystic group of salivary gland cancers: one or more druggable entities?

scientific article published on 04 April 2019

Immunotherapy for recurrent/metastatic head and neck cancer

artículo científico publicado en 2018

In situ hybridization detection methods for HPV16 E6/E7 mRNA in identifying transcriptionally active HPV infection of oropharyngeal carcinoma: an updating

artículo científico publicado en 2017

Investigational drugs for head and neck cancer

artículo científico publicado en 2016

Lenvatinib-induced renal failure: two first-time case reports and review of literature.

artículo científico publicado en 2018

Management of tyrosine kinase inhibitors (TKI) side effects in differentiated and medullary thyroid cancer patients.

artículo científico publicado en 2017

New toxicity profile for novel immunotherapy agents: focus on immune-checkpoint inhibitors.

artículo científico publicado en 2015

Outcome of recurrent and metastatic head and neck squamous cell cancer patients after first line platinum and cetuximab therapy.

artículo científico publicado en 2017

PD-1 blockade therapy in renal cell carcinoma: current studies and future promises.

artículo científico publicado en 2015

PD-L1 Expression in Unresectable Locally Advanced or Metastatic Skin Squamous Cell Carcinoma Treated with Anti-Epidermal Growth Factor Receptor Agents

artículo científico publicado en 2019

Phase II trial with axitinib in recurrent and/or metastatic salivary gland cancers of the upper aerodigestive tract

scientific article published on 29 July 2019

Preemptive treatment with Xonrid®, a medical device to reduce radiation induced dermatitis in head and neck cancer patients receiving curative treatment: a pilot study

artículo científico publicado en 2017

Prevalence of Fatigue in Head and Neck Cancer Survivors

artículo científico publicado en 2019

Prognostic and predictive factors in recurrent and/or metastatic head and neck squamous cell carcinoma: A review of the literature

artículo científico publicado en 2019

Prognostic nomogram in patients with metastatic adenoid cystic carcinoma of the salivary glands

artículo científico publicado en 2020

Prognostic role of PIK3CA and TP53 in human papillomavirus-negative oropharyngeal cancers

artículo científico publicado en 2018

RANK expression in EBV positive nasopharyngeal carcinoma metastasis: a ready-to-treat target?

artículo científico publicado en 2017

Retreatment with Vismodegib after Progression in Advanced Basal Cell Carcinoma: First-Time Report of a Single-Institution Experience

artículo científico publicado en 2017

Role of IMRT/VMAT-Based Dose and Volume Parameters in Predicting 5-Year Local Control and Survival in Nasopharyngeal Cancer Patients

artículo científico publicado en 2020

Role of pretreatment 18F-FDG PET/CT parameters in predicting outcome of non-endemic EBV DNA-related nasopharyngeal cancer (NPC) patients treated with IMRT and chemotherapy

artículo científico publicado en 2018

Safety of combination treatment with imatinib mesylate, carboplatin, and cetuximab in a patient with multiple cancers: a case report

artículo científico publicado en 2016

Salivary Cytokine Levels and Oral Mucositis in Head and Neck Cancer Patients Treated With Chemotherapy and Radiation Therapy

artículo científico publicado en 2016

Surveillance of Patients with Head and Neck Cancer with an Intensive Clinical and Radiologic Follow-up

scientific article published on 09 July 2019

Systemic therapy in metastatic salivary gland carcinomas: A pathology-driven paradigm?

artículo científico publicado en 2017

Tailoring treatment of salivary duct carcinoma (SDC) by liquid biopsy: ARv7 expression in circulating tumor cells

artículo científico publicado en 2018

Temporal course and predictive factors of analgesic opioid requirement for chemoradiation-induced oral mucositis in oropharyngeal cancer.

artículo científico publicado en 2016

The Benefit of a Multidisciplinary Approach to the Patient Treated with (Chemo) Radiation for Head and Neck Cancer

artículo científico publicado en 2016

The Case Volume Issue in Head and Neck Oncology

artículo científico publicado en 2017

The dilemma of metastatic medullary thyroid carcinoma: when to start systemic treatment

artículo científico publicado en 2019

The point of pain in head and neck cancer

scientific article published on 05 April 2019

Treatment challenges in and outside a network setting: Head and neck cancers.

artículo científico publicado en 2018

Tumor Biomarkers for the Prediction of Distant Metastasis in Head and Neck Squamous Cell Carcinoma

scientific article published on 09 April 2020

Lista de obras de Salvatore Alfieri

A phase II study of sorafenib in recurrent and/or metastatic salivary gland carcinomas: Translational analyses and clinical impact.

A randomized, double-blind, placebo controlled, phase II study to evaluate the efficacy of ginseng in reducing fatigue in patients treated for head and neck cancer

A randomized, double-blind, placebo-controlled, multicenter study of a ginger extract in the management of chemotherapy-induced nausea and vomiting (CINV) in patients receiving high-dose cisplatin

Activity of platinum and cetuximab in cutaneous squamous cell cancer not amenable to curative treatment

Baseline MRI-Radiomics Can Predict Overall Survival in Non-Endemic EBV-Related Nasopharyngeal Carcinoma Patients

Baseline neutrophil-to-lymphocyte ratio is associated with outcome of ipilimumab-treated metastatic melanoma patients

Bone metastases from head and neck malignancies: Prognostic factors and skeletal-related events

Circulating pre-treatment Epstein-Barr virus DNA as prognostic factor in locally-advanced nasopharyngeal cancer in a non-endemic area.

Dabrafenib in metastatic melanoma: a monocentric 'real life' experience

Does a multidisciplinary team approach in a tertiary referral centre impact on the initial management of head and neck cancer?

Efficacy and safety of single-agent pan-human epidermal growth factor receptor (HER) inhibitor dacomitinib in locally advanced unresectable or metastatic skin squamous cell cancer

Eliciting Preferences for Clinical Follow-Up in Patients with Head and Neck Cancer Using Best-Worst Scaling.

Gene Expression Signatures for Head and Neck Cancer Patient Stratification: Are Results Ready for Clinical Application?

Genomics in non-adenoid cystic group of salivary gland cancers: one or more druggable entities?

Immunotherapy for recurrent/metastatic head and neck cancer

In situ hybridization detection methods for HPV16 E6/E7 mRNA in identifying transcriptionally active HPV infection of oropharyngeal carcinoma: an updating

Investigational drugs for head and neck cancer

Lenvatinib-induced renal failure: two first-time case reports and review of literature.

Management of tyrosine kinase inhibitors (TKI) side effects in differentiated and medullary thyroid cancer patients.

New toxicity profile for novel immunotherapy agents: focus on immune-checkpoint inhibitors.

Outcome of recurrent and metastatic head and neck squamous cell cancer patients after first line platinum and cetuximab therapy.

PD-1 blockade therapy in renal cell carcinoma: current studies and future promises.

PD-L1 Expression in Unresectable Locally Advanced or Metastatic Skin Squamous Cell Carcinoma Treated with Anti-Epidermal Growth Factor Receptor Agents

Phase II trial with axitinib in recurrent and/or metastatic salivary gland cancers of the upper aerodigestive tract

Preemptive treatment with Xonrid®, a medical device to reduce radiation induced dermatitis in head and neck cancer patients receiving curative treatment: a pilot study

Prevalence of Fatigue in Head and Neck Cancer Survivors

Prognostic and predictive factors in recurrent and/or metastatic head and neck squamous cell carcinoma: A review of the literature

Prognostic nomogram in patients with metastatic adenoid cystic carcinoma of the salivary glands

Prognostic role of PIK3CA and TP53 in human papillomavirus-negative oropharyngeal cancers

RANK expression in EBV positive nasopharyngeal carcinoma metastasis: a ready-to-treat target?

Retreatment with Vismodegib after Progression in Advanced Basal Cell Carcinoma: First-Time Report of a Single-Institution Experience

Role of IMRT/VMAT-Based Dose and Volume Parameters in Predicting 5-Year Local Control and Survival in Nasopharyngeal Cancer Patients

Role of pretreatment 18F-FDG PET/CT parameters in predicting outcome of non-endemic EBV DNA-related nasopharyngeal cancer (NPC) patients treated with IMRT and chemotherapy

Safety of combination treatment with imatinib mesylate, carboplatin, and cetuximab in a patient with multiple cancers: a case report

Salivary Cytokine Levels and Oral Mucositis in Head and Neck Cancer Patients Treated With Chemotherapy and Radiation Therapy

Surveillance of Patients with Head and Neck Cancer with an Intensive Clinical and Radiologic Follow-up

Systemic therapy in metastatic salivary gland carcinomas: A pathology-driven paradigm?

Tailoring treatment of salivary duct carcinoma (SDC) by liquid biopsy: ARv7 expression in circulating tumor cells

Temporal course and predictive factors of analgesic opioid requirement for chemoradiation-induced oral mucositis in oropharyngeal cancer.

The Benefit of a Multidisciplinary Approach to the Patient Treated with (Chemo) Radiation for Head and Neck Cancer

The Case Volume Issue in Head and Neck Oncology

The dilemma of metastatic medullary thyroid carcinoma: when to start systemic treatment

The point of pain in head and neck cancer

Treatment challenges in and outside a network setting: Head and neck cancers.

Tumor Biomarkers for the Prediction of Distant Metastasis in Head and Neck Squamous Cell Carcinoma